Cancer Communications (Mar 2024)
Mitochondria‐targeted atovaquone promotes anti‐lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti‐tumor immune cells
Abstract
No abstracts available.
Cancer Communications (Mar 2024)